MeadowBrook Investment Advisors LLC Acquires New Holdings in HealthEquity, Inc. (NASDAQ:HQY)

MeadowBrook Investment Advisors LLC purchased a new stake in shares of HealthEquity, Inc. (NASDAQ:HQY) during the 4th quarter, Holdings Channel.com reports. The fund purchased 4,410 shares of the company’s stock, valued at approximately $292,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Xponance Inc. lifted its stake in shares of HealthEquity by 1.2% during the 4th quarter. Xponance Inc. now owns 12,269 shares of the company’s stock valued at $813,000 after buying an additional 147 shares in the last quarter. Fifth Third Bancorp grew its position in shares of HealthEquity by 36.5% during the third quarter. Fifth Third Bancorp now owns 602 shares of the company’s stock worth $44,000 after purchasing an additional 161 shares in the last quarter. HighTower Advisors LLC raised its stake in HealthEquity by 0.4% during the 3rd quarter. HighTower Advisors LLC now owns 86,940 shares of the company’s stock valued at $6,366,000 after purchasing an additional 340 shares during the period. Mariner LLC boosted its stake in HealthEquity by 2.4% in the 3rd quarter. Mariner LLC now owns 14,983 shares of the company’s stock worth $1,095,000 after purchasing an additional 345 shares during the period. Finally, McGlone Suttner Wealth Management Inc. purchased a new stake in HealthEquity during the 4th quarter valued at approximately $29,000. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

HealthEquity Stock Up 0.9 %

Shares of HQY traded up $0.73 during mid-day trading on Tuesday, reaching $80.00. The company’s stock had a trading volume of 160,849 shares, compared to its average volume of 586,134. The company has a debt-to-equity ratio of 0.43, a current ratio of 4.76 and a quick ratio of 4.76. HealthEquity, Inc. has a 12-month low of $53.15 and a 12-month high of $84.49. The stock has a market cap of $6.86 billion, a PE ratio of 123.86, a price-to-earnings-growth ratio of 1.28 and a beta of 0.55. The company’s 50 day moving average is $80.72 and its 200 day moving average is $74.67.

HealthEquity (NASDAQ:HQY) last released its earnings results on Tuesday, March 19th. The company reported $0.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.42 by $0.08. The company had revenue of $262.39 million for the quarter, compared to analysts’ expectations of $258.56 million. HealthEquity had a return on equity of 6.91% and a net margin of 5.57%. Equities analysts anticipate that HealthEquity, Inc. will post 2.12 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on HQY shares. JPMorgan Chase & Co. boosted their target price on shares of HealthEquity from $86.00 to $108.00 and gave the stock an “overweight” rating in a report on Tuesday, April 2nd. Royal Bank of Canada lifted their price objective on HealthEquity from $90.00 to $92.00 and gave the stock an “outperform” rating in a report on Wednesday, March 20th. JMP Securities initiated coverage on shares of HealthEquity in a research note on Thursday, April 4th. They set a “mkt outperform” rating and a $101.00 price objective for the company. Barrington Research restated an “outperform” rating and set a $100.00 price target on shares of HealthEquity in a research note on Friday, March 22nd. Finally, KeyCorp increased their price target on shares of HealthEquity from $85.00 to $95.00 and gave the stock an “overweight” rating in a research report on Friday, March 22nd. One investment analyst has rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $96.17.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, Director Evelyn S. Dilsaver sold 32,500 shares of the company’s stock in a transaction dated Tuesday, March 26th. The shares were sold at an average price of $79.29, for a total transaction of $2,576,925.00. Following the transaction, the director now directly owns 32,123 shares in the company, valued at $2,547,032.67. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other HealthEquity news, EVP Delano Ladd sold 2,558 shares of the company’s stock in a transaction dated Friday, March 1st. The shares were sold at an average price of $82.59, for a total value of $211,265.22. Following the sale, the executive vice president now owns 47,438 shares of the company’s stock, valued at $3,917,904.42. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Evelyn S. Dilsaver sold 32,500 shares of HealthEquity stock in a transaction that occurred on Tuesday, March 26th. The stock was sold at an average price of $79.29, for a total value of $2,576,925.00. Following the transaction, the director now owns 32,123 shares of the company’s stock, valued at $2,547,032.67. The disclosure for this sale can be found here. Over the last quarter, insiders sold 71,322 shares of company stock valued at $5,682,895. 2.70% of the stock is owned by company insiders.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.